Łoboda Agnieszka, Mucha Olga, Podkalicka Paulina, Sobczak Mateusz, Miksza-Cybulska Anna, Kaczara Patrycja, Jozkowicz Alicja, Dulak Jozef
Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland.
1Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland; 2Kardio-Med Silesia, Zabrze, Poland.
Acta Biochim Pol. 2018 Nov 27;65(4):613-620. doi: 10.18388/abp.2018_2658.
Cyclosporine A (CsA), a widely used immunosuppressive drug, exerts nephrotoxic activities, as demonstrated by increased tubulointerstitial fibrosis, inflammation and podocyte damage. Recently, a number of microRNAs expressed in the kidney have been reported to be elevated during renal damage. Our aim was to investigate the effect of CsA on selected microRNAs in the mouse kidney after CsA treatment. Moreover, as heme oxygenase-1 (HO-1, encoded by the Hmox1 gene) was shown to play a protective role during kidney disorders, we assessed whether HO-1 deficiency in vivo influences the CsA-regulated microRNAs' expression. We have observed that the pro-fibrotic miR-21 and pro-apoptotic miR-34a expression was upregulated in kidneys of HO-1 deficient mice and it was further enhanced by CsA. Concomitantly, the level of anti-fibrotic microRNAs, belonging to miR-29 and miR-200 families, was down-regulated after CsA treatment. Generally, Hmox1 knock-out (Hmox1-/-) animals were more susceptible to CsA treatment, as the mortality rate was 4 out of 9 Hmox1-/- mice, and increased fibrosis (Tgfb2, Pai1), inflammation (Il6) and apoptosis (Cdkn1a-p21) were noticed in the HO-1 deficient kidneys. In summary, our data demonstrate that CsA induces significant changes in the expression of renal microRNAs and emphasize HO-1 deficiency as an important factor contributing to the CsA-mediated renal toxicity.
环孢素A(CsA)是一种广泛使用的免疫抑制药物,具有肾毒性,表现为肾小管间质纤维化、炎症和足细胞损伤增加。最近,有报道称肾脏中表达的一些微小RNA在肾损伤期间会升高。我们的目的是研究CsA处理后对小鼠肾脏中特定微小RNA的影响。此外,由于血红素加氧酶-1(HO-1,由Hmox1基因编码)在肾脏疾病中发挥保护作用,我们评估了体内HO-1缺乏是否会影响CsA调节的微小RNA的表达。我们观察到,在HO-1缺陷小鼠的肾脏中,促纤维化的miR-21和促凋亡的miR-34a表达上调,并且CsA进一步增强了这种上调。同时,属于miR-29和miR-200家族的抗纤维化微小RNA水平在CsA处理后下调。总体而言,Hmox1基因敲除(Hmox1-/-)动物对CsA处理更敏感,因为9只Hmox1-/-小鼠中有4只死亡,并且在HO-1缺陷的肾脏中观察到纤维化(Tgfb2、Pai1)、炎症(Il6)和凋亡(Cdkn1a-p21)增加。总之,我们的数据表明CsA诱导肾脏微小RNA表达发生显著变化,并强调HO-1缺乏是导致CsA介导的肾毒性的重要因素。